Marksans Pharma informs about press release

20 Mar 2025 Evaluate
Marksans Pharma has informed that it enclosed press release. Marksans Pharma (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) announced that its manufacturing facility located at Plot A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa has been approved by Australian TGA for manufacture of pharmaceutical formulations in Solid Dosage Forms of Tablets and hard Capsules for Australian markets. The products will be manufactured at the above facility in Goa India and marketed & distributed in Australian markets through the Company’s subsidiary Nova Pharmaceuticals Australasia.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

221.70 -0.65 (-0.29%)
01-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...